All Products
Also known as
Inflatable penile prosthesis (when used as tissue expander), IPP tissue expander, corporal tissue expander, penile prosthetic expander, downsized prosthetic expander, mechanical tissue stretcher
Definition
A tissue expander is a prosthetic device specifically designed to gradually stretch fibrotic corporal tissue through controlled mechanical expansion. In urological applications, tissue expanders often function as inflatable penile prostheses (IPPs) that serve a dual purpose: providing a degree of erectile function while simultaneously expanding scarred or fibrotic corporal tissue over time1. These devices work by applying consistent radial pressure to the tunica albuginea and corporal spaces. This pressure is believed to induce mechanotransduction pathways that stimulate cellular adaptation and tissue remodeling, effectively allowing for gradual tissue expansion2. The expansion process typically requires regular inflation cycles over a period of 8-12 months to achieve optimal tissue stretching, which can allow for subsequent implantation of larger prosthesis cylinders or improved corporal accommodation for an existing or future implant3.
Clinical Context
The use of an inflatable penile prosthesis as a tissue expander is clinically indicated for patients with severe corporal fibrosis secondary to conditions such as priapism, previous prosthetic infections, extensive Peyronie’s disease, or multiple failed penile reconstructive surgeries1. Patient selection criteria include adequate vascular supply to the penis, absence of active infection, and realistic patient expectations regarding the expansion process, timeline, and potential outcomes. The surgical procedure typically involves the initial implantation of appropriately sized, often downsized, IPP cylinders. This is followed by a structured inflation protocol, which may involve daily or regular cycling of the device for a period of 8-12 months or longer, as determined by the clinical goals and patient response1. Clinical studies have demonstrated that this approach can lead to significant increases in implantable cylinder length (e.g., 0.9-1.2 cm after ≥2 years of expansion in some cohorts), with a substantial percentage of patients achieving measurable gains (e.g., 60% achieving >0.5 cm increases and 40% achieving ≥1 cm increases)1. Success rates for subsequent upsizing procedures in appropriately selected patients are reported to be high (approaching 90-95%), with minimal complications when proper surgical technique is employed and patient adherence to the protocol is maintained2.